FindTrial
Sign In

Two Different Drugs To See Effect on Recovery Time IN Laparoscopic Surgery.

Comparing Desflurane Vs Sevoflurane For Effect On Recovery Time In Patient Undergoing Laparoscopic Surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/049021
Enrollment
60
Registered
2023-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K802- Calculus of gallbladder without cholecystitis Health Condition 2: K802- Calculus of gallbladder without cholecystitis Health Condition 3: O- Medical and Surgical

Interventions

Control Intervention1: Desflurane : Desflurane (3-6%),50%o2+50%N2o given for 2 hour of duration of surgery. Control Intervention2: Sevoflurane: Sevoflurane (1-2%),50%o2+50%N2o given for 2 hour of dur

Sponsors

Health and family welfare department
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I,ASA II patients Patients undergoing Laparoscopic surgeries Written and informed consent.

Exclusion criteria

Exclusion criteria: Patient refusal to participate in study Those with clinically significant cardiovascular, respiratory, hepatic, renal, neurologic, psychiatric or metabolic disease. ASA GRADE III and GRADE IV patients Pregnant women Morbid obesity Patients of less than 20 years and more than 50 years of age

Design outcomes

Primary

MeasureTime frame
Assessment of recovery and hemodynemic stability during inhalation agent administration in laparoscopic . surgeryTimepoint: 5min,10min,15min,30min,45min,60min, 75min,90min,120min,150min—

Secondary

MeasureTime frame
Nausea,vomiting,drowsiness,tachycardia,hypertension,respiratory distressTimepoint: After extubation 30 min—

Countries

India

Contacts

Public ContactDrChandresh Shah

B.J .Medical College,Ahmedabad

csshah298@gmail.com9328972082

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026